PILOT STUDY FOR THE USE OF SHORTENED PREEMPTIVE THERAPY WITH GLECAPREVIR/PIBRENTASVIR AND EZETIMIBE IN HEPATITIS C SERONEGATIVE SOLID ORGAN TRANSPLANT RECIPIENTS (KIDNEY/HEART) OF HEPATITIS C VIREMIC DONORS

被引：0
|
作者：
Aqel, Bashar
Moss, Adyr A.
Dickson, Rolland
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
432
引用
收藏
页码：S776 / S776
页数：1
相关论文
共 50 条
  • [1] Pilot Study for the Use of Shortened Preemptive Therapy with Glecaprevir/pibrentasvir (g/p) and Ezetimibe in Hepatitis C Seronegative Solid Organ Transplant Recipients (Kidney and Heart) of Hepatitis C Viremic Donors
    Aqel, B.
    Khamash, H.
    Moss, A.
    Steidley, D. E.
    Dickson, R. C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 489 - 490
  • [2] MULTICENTER PROSPECTIVE STUDY FOR THE USE OF SHORTENED PREEMPTIVE THERAPY WITH GLECAPREVIR/PIBRENTASVIR (G/P) AND EZETIMIBE IN HEPATITIS C SERONEGATIVE NON-LIVER SOLID ORGAN TRANSPLANT (TX) RECIPIENTS OF HEPATITIS C (HCV) VIREMIC DONORS
    Aqel, Bashar A.
    Pungpapong, Surakit
    Moss, Adyr
    Ryland, Kristen
    Dickson, Rolland
    [J]. HEPATOLOGY, 2021, 74 : 597A - 597A
  • [3] Multicenter prospective study for the use of shortened pre-emptive therapy with Glecaprevir/Pibrentasvir (G/P) and Ezetimibe in hepatitis C (HCV) seronegative non-liver solid organ transplant recipients of HCV viremic grafts
    Aqel, Bashar
    Pungpapong, Surakit
    Moss, Adyr
    Dickson, Rolland
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S15 - S16
  • [4] Management and tolerability of glecaprevir-pibrentasvir pharmacotherapy in hepatitis C viremic heart and lung transplant recipients
    Lewis, Tyler C.
    Gidea, Claudia
    Reyentovich, Alex
    Angel, Luis
    Lesko, Melissa
    Pavone, Jennifer
    Sureau, Kimberly
    Smith, Deane E., III
    Kon, Zachary
    Moazami, Nader
    [J]. CLINICAL TRANSPLANTATION, 2020, 34 (10)
  • [5] Use of Crushed Glecaprevir/Pibrentasvir in Hepatitis C Positive Donor Heart Transplant Recipients
    Waldman, G.
    Bethea, E.
    Gustafson, J.
    Cote, M.
    Gift, T.
    Rogers, C.
    Shao, S.
    Villavicencio, M.
    D'Alessandro, D.
    Chung, R.
    Lewis, G.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S95 - S96
  • [6] Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors
    Reyentovich, Alex
    Gidea, Claudia G.
    Smith, Deane
    Lonze, Bonnie
    Kon, Zachary
    Fargnoli, Anthony
    Pavone, Jennifer
    Rao, Shaline
    Saraon, Tajinderpal
    Lewis, Tyler
    Qian, Yingzhi
    Jacobson, Ira
    Moazami, Nader
    [J]. CLINICAL TRANSPLANTATION, 2020, 34 (09)
  • [7] HEPATITIS C VIREMIC DONORS TO HEPATITIS C NEGATIVE RECIPIENTS IN SOLID ORGAN TRANSPLANTATION: A SYSTEMATIC REVIEW
    Raasikh, Taaj
    Jamali, Taher
    Flores, Avegail
    Cotton, Ronald
    Ramanathan, Venkat
    Tan, Henkie P.
    Hernaez, Ruben
    [J]. HEPATOLOGY, 2020, 72 : 808A - 809A
  • [8] Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
    Axelrod, David A.
    Lentine, Krista L.
    Balakrishnan, Ramji
    Chang, Su-Hsin
    Alhamad, Terek
    Xiao, Huiling
    Kasiske, Bertran L.
    Bloom, Roy D.
    Schnitzler, Mark A.
    [J]. TRANSPLANTATION DIRECT, 2020, 6 (12): : E627
  • [9] Hepatitis C in organ donors and heart transplant recipients - Reply
    Gasink, Leanne B.
    Blumberg, Emily A.
    Localio, A. Russell
    Lautenbach, Ebbing
    Desai, Shashank S.
    Israni, Ajay K.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (07): : 696 - 697
  • [10] Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients
    Zhu, Yuanjia
    Shudo, Yasuhiro
    Lee, Roy
    Woo, Y. Joseph
    [J]. ANNALS OF TRANSPLANTATION, 2020, 25 : 1 - 9
12345